Articles
| Open Access |
DOI: DIAGNOSTICS AND TREATMENT OF CHRONIC CEREBRAL CIRCULATORY DISORDERS AGAINST THE BACKGROUND OF DIABETES MELLITUS
Dzhurabekova Aziza Takhirovna , Professor, Head Of Department Of Neurology Samarkand State Medical University, Uzbekistan Shaymatov Rakhmonberdi Uktamovich , Resident Of Ma Course Of Neurology Department Samarkand State Medical University, UzbekistanAbstract
Diabetes mellitus is undoubtedly due to the high medical and social significance of diabetes, which affects mostly young people and causes complications of the nervous system, both central and peripheral. The leading complication of diabetes is diabetic encephalopathies (DEC), forming cognitive impairment, reducing the quality of life (QOL) of patients, leading to disability and as the most fatal manifestation - death.
Keywords
Diabetes mellitus, chronic cerebral circulatory disorders, diabetic encephalopathy
References
Strokov I.A., Zakharov V.V., Strokov K.I. Diabetic encephalopathy. Current state of the problem // Doktor.Ru. 2013. №7-2 (85), с. 29-35. URL: https://cyberleninka.ru/article/n/diabeticheskaya-entsefalopatiya-sovremennoe-sostoyanie-problemy (access date: 02.05.2023).
Bykov Y.V. Oxidative stress and diabetic encephalopathy: pathophysiological aspects // Modern problems of science and education. 2022. No. 6-2.; URL: https://science-education.ru/ru/article/view?id=32314 (date of reference: 02.05.2023).
Sivtsova A.A., Simonova V.G. Diabetic encephalopathy as a cause of cognitive impairment // International Student Scientific Bulletin. 2023. No. 2.; URL: https:// eduherald.ru/ru/article/view?id=21260 (date of reference: 02.05.2023).
Martsevich S.Y., Tolpygina S.N., Zagrebelny A.V., Chernysheva M.I., Voronina V.P., Kutishenko N.P., Dmitrieva N.A., Lerman O.V., Lukina Y.V., Blagodatsky S.V., Lukyanov M.M., Okshina E.Y., Parsadanyan N.E, Drapkina O.M. Quality of drug therapy of patients who suffered cerebral stroke depending on the presence or absence of diabetes mellitus at the outpatient stage of the REGION-M registry // Cardiovascular Therapy and Prevention. 2021; № 20(5): с. 60-66, 2856. https://doi.org/10.15829/1728-8800-2021-2856
Akhtar N., Singh R, Kamran S., Babu B., Sivasankaran S., Joseph S., Morgan D. and Shuaib A. Diabetes: Chronic Metformin Treatment and Outcome Following Acute Stroke. // Front. Neurol. 2022, № 13: 849607. doi: 10.3389/fneur.2022.849607.
Mosenzon O, Cheng AY, Rabinstein AA, Sacco S. Diabetes and Stroke: What Are the Connections? // J Stroke. 2023; № 25(1): р. 26-38. doi:10.5853/jos.2022.02306
Gian Paolo Fadini, Francesco Cosentino Diabetes and ischaemic stroke: a deadly association // European Heart Journal, 2018, no. 39(25), p. 2387-2389, https://doi.org/10.1093/eurheartj/ehy033
Maida CD, Daidone M, Pacinella G, Norrito RL, Pinto A, Tuttolomondo A. Diabetes and Ischemic Stroke: An Old and New Relationship an Overview of the Close Interaction between These Diseases. // In International Journal of Molecular Sciences. 2022; 23(4): 2397. ttps://doi.org/10.3390/ijms23042397
Gaillard T, Miller E. Guidelines for stroke survivors with diabetes mellitus. // Stroke. 2018;49(6):e215-e217. doi:10.1161/STROKEAHA.118.020745
Ermolaeva A.I. Peculiarities of the course of cerebrovascular diseases in type 2 diabetes mellitus and hypothyroidism // Autoref. d.m., Moscow, 2009, 50 p.
Shimkina N.F., Barantsevich E.R. Structure of cognitive disorders in patients with type 1 diabetes in the absence of focal neurological symptoms. // Siberian Medical Review. 2017; (1): 49-53. DOI: 10.20333/2500136-2017-1-49-53Shomuradova D.S., Jurabekova A.T. Complex Interrelationship of Clinical and Neurological Disorders with Thyroid Dysfunction in the Elderly // American Journal of Medicine and Medical Sciences 2023, 13(4): 383-387, DOI: 10.5923/j.ajmms.20231304.09
Rajabov S.A., Djurabekova A.T. Determination of early diagnostic and neurological signs in patients with systemic lupus erythematosus. // World Bulletin of Public Health, 2023. № 20, с. 64-70.
Article Statistics
Copyright License
Copyright (c) 2023 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.